Skip to main content
Top
Published in: European Journal of Nutrition 1/2013

01-02-2013 | Erratum

Erratum to: Carbon and nitrogen isotopic ratios of urine and faeces as novel nutritional biomarkers of meat and fish intake

Authors: Gunter G. C. Kuhnle, Annemiek M. C. P. Joosen, Catherine J. Kneale, Tamsin C. O’Connell

Published in: European Journal of Nutrition | Issue 1/2013

Login to get access

Excerpt

In the original publication, Table 2 was published incorrectly as the values for urine and faeces were inadvertently interchanged. The corrected table is given below.
Table 2
Isotope ratios (δ 13C and δ 15N) of blood, faeces and urine (median and inter-quartile range)
Diet group
n
δ 13C (‰)
δ 15N (‰)
Blooda
 Fish
13
−22.7 (−23.0 to −22.6)
8.5 (8.4–8.6)
 Meat/fish
11
−23.0 (−23.2 to −22.6)
8.5 (8.3–8.7)
 Meat
14
−22.8 (−23.1 to −22.5)
8.5 (8.3–8.7)
 Vegetarian
Urineb
 Fish
14
−23.2 (−23.4 to −22.9)
6.7 (6.3–6.8)
 Meat/fish
13
−24.0 (−24.3 to −23.5)
5.7 (5.2–6.0)
 Meat
14
−24.3 (−24.4 to −23.8)
5.6 (5.5–5.9)
 Vegetarian
4
−24.8 (−25.0 to −24.5)
3.5 (3.4–3.8)
Faecesb
 Fish
14
−25.8 (−26.2 to −25.5)
7.8 (7.3–8.1)
 Meat/fish
13
−26.4 (−26.6 to −26.2)
7.0 (6.8–7.8)
 Meat
14
−26.5 (−26.7 to −26.3)
6.9 (6.7–7.2)
 Vegetarian
4
−27.2 (−27.4 to −27.0)
5.0 (4.5–5.4)
aNo significant differences between diets (p > 0.6 for δ 13C and δ 15N, Kruskal–Wallis test)
bSignificant differences between diets (p < 0.0005 for δ 13C and δ 15N, Kruskal–Wallis test)
Metadata
Title
Erratum to: Carbon and nitrogen isotopic ratios of urine and faeces as novel nutritional biomarkers of meat and fish intake
Authors
Gunter G. C. Kuhnle
Annemiek M. C. P. Joosen
Catherine J. Kneale
Tamsin C. O’Connell
Publication date
01-02-2013
Publisher
Springer-Verlag
Published in
European Journal of Nutrition / Issue 1/2013
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-012-0471-9

Other articles of this Issue 1/2013

European Journal of Nutrition 1/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.